ALX Oncology Holdings Inc.ALXONASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-122.36M
↓ 77% below average
Average (6y)
$-69.21M
Historical baseline
Range
High:$-13.84M
Low:$-131.64M
CAGR
+43.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-122.36M | +7.0% |
| 2023 | $-131.64M | -45.2% |
| 2022 | $-90.65M | -24.1% |
| 2021 | $-73.02M | -90.6% |
| 2020 | $-38.32M | -162.4% |
| 2019 | $-14.60M | -5.5% |
| 2018 | $-13.84M | - |